• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WATCHMAN FLX LAA CLOSURE DEVICE & DELIVERY SYSTEM; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WATCHMAN FLX LAA CLOSURE DEVICE & DELIVERY SYSTEM; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL Back to Search Results
Device Problem Difficult to Open or Close (2921)
Patient Problems Low Blood Pressure/ Hypotension (1914); Perforation (2001); Pericardial Effusion (3271)
Event Date 05/09/2022
Event Type  Injury  
Event Description
Literature article.It was reported that there was a pericardial effusion.A left atrial appendage (laa) closure procedure was being performed.A watchman access system (was) was positioned and a 27mm watchman flx laa closure device & delivery system (wds) were used.The physician positioned the was in the laa of the patient and then inserted the wds.The closure device was deployed and all release criteria was met.The closure device was released from the core wire and successfully implanted in the laa of the patient.Post closure device release the physician noted that the patient had a moderate to large pericardial effusion.The patient became hypotensive and needed vasopressor support.The physician performed a pericardiocentesis and drained 600ml of blood from the patient.A transthoracic echocardiogram showed that the effusion was not improving and another 350ml of blood was removed from the patient over 30 minutes.The physician believed that there was a perforation of the la so the patient was brought to the operating room for open heart surgery.During surgery a perforation was noted and repaired.It was noted that the closure device had shifted in the laa and there was a peri-device leak.The surgeon removed the closure device from the patient and resected the laa.The patient fully recovered from this event and was discharged from the hospital doing well.
 
Manufacturer Narrative
D.Al rameni, i.S.De armas, a.Al rameeni, et al., case report: watchman procedure complicated by atrial perforation and device dislodgement, cardiovascular revascularization medicine, https://doi.Org/10.1016/j.Carrev.2022.05.009.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WATCHMAN FLX LAA CLOSURE DEVICE & DELIVERY SYSTEM
Type of Device
SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key15422355
MDR Text Key299924918
Report Number2124215-2022-35698
Device Sequence Number1
Product Code NGV
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 09/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/01/2022
Initial Date FDA Received09/14/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age75 YR
Patient SexFemale
-
-